Coreena Brinck

(she/her)

Coreena Brinck

Dehns

Partner & Head of AI Development

ABOUT THE SPEAKER

Coreena Brinck is a European and UK Patent Attorney with more than two decades of experience helping innovative companies turn complex ideas into valuable, defensible intellectual property assets. She specialises in IP strategy for technologies sitting at the edge of patent eligibility, including software, AI, machine learning, communications and complex technical systems. As Partner and Head of AI Development at Dehns, Coreena brings a rare mix of legal, technical and strategic expertise. Her background includes senior IP roles at Nokia Technologies, BT, CMS and Zacco, alongside deep academic grounding in physics, space physics, telecommunications and applied mathematics. She is also a regular speaker and thought leader on emerging IP challenges, innovation policy and the intersection of technology and patent law.

Sessions

Nicolas Huber

Mark Crowter

Osmin Callis

Becci Edmondson

14:40

-

15:20

Panel

Collaborators Stage

Impact Over Optics: What Innovation Looks Like When Outcomes Actually Matter

Innovation is often judged by visibility, speed and scale. But in environments where outcomes have real consequences, those measures don’t hold up. In sectors like healthcare, decisions are not just about growth or engagement. They affect real people, with real risk attached. This changes how innovation works. This panel explores what it means to prioritise impact over optics. How organisations define success when metrics are not enough, what trade-offs are made when impact and growth don’t align, and how teams operate when accountability is higher. It also looks at the reality of working across complex systems, clinicians, academics, industry and regulators, where progress is slower, but the stakes are higher. Because when outcomes actually matter, the way we build, measure and talk about innovation has to change.

Nicolas Huber

Mark Crowter

Osmin Callis

Becci Edmondson

14:40

-

15:20

Panel

Collaborators Stage

Impact Over Optics: What Innovation Looks Like When Outcomes Actually Matter

Innovation is often judged by visibility, speed and scale. But in environments where outcomes have real consequences, those measures don’t hold up. In sectors like healthcare, decisions are not just about growth or engagement. They affect real people, with real risk attached. This changes how innovation works. This panel explores what it means to prioritise impact over optics. How organisations define success when metrics are not enough, what trade-offs are made when impact and growth don’t align, and how teams operate when accountability is higher. It also looks at the reality of working across complex systems, clinicians, academics, industry and regulators, where progress is slower, but the stakes are higher. Because when outcomes actually matter, the way we build, measure and talk about innovation has to change.